MARKET WIRE NEWS

Forager Capital Management Submits Fully Financed Proposal to Acquire Quipt Home Medical for $3.10 Per Share in Cash

MWN-AI** Summary

BIRMINGHAM, Ala., August 25, 2025 (GLOBE NEWSWIRE) – Forager Capital Management, a significant stakeholder in Quipt Home Medical Corp. (NASDAQ: QIPT; TSX: QIPT) with 9.7% ownership, has announced a fully financed acquisition proposal to buy all outstanding shares of Quipt for $3.10 per share in cash. This offer, referred to as the “Acquisition Proposal,” is notable as it is not contingent upon due diligence or additional financing, enabling immediate execution upon acceptance.

The proposed price represents a substantial 120% premium over Quipt’s closing share price of $1.41 on May 19, 2025, prior to Forager's previous proposal becoming public. Forager Capital Management emphasizes its readiness to enhance its offer should Quipt's Board engage in meaningful discussions regarding the proposal.

Additionally, the Acquisition Proposal includes a "go-shop" provision, allowing Quipt's Board to seek alternative offers post-signing of definitive agreements. This provision is designed to encourage competitive bids, enabling other potential buyers to present superior offers should they exist.

Forager Capital's Chairman reiterates that this proposal is structured to deliver immediate and guaranteed value to Quipt's shareholders, positioning it as a strategic move for stakeholders concerned about the company’s future growth and stability. The formal details of the proposal will be made available through an amended Schedule 13D filing.

Investors and analysts are closely watching for Quipt's Board response, with industry expectations that a constructive dialogue could lead to an improved offer from Forager, enhancing the overall value for shareholders. As such, this bid marks a significant development in the ongoing dynamics of the healthcare sector, particularly within the medical supply industry.

MWN-AI** Analysis

Forager Capital Management's recent proposal to acquire Quipt Home Medical Corp. for $3.10 per share represents a significant opportunity for investors. The offer, which is a substantial 120% premium over the stock’s unaffected price prior to the reveal of Forager's earlier proposal, underscores the potential value that Forager sees in Quipt.

The immediate execution of this fully financed offer, devoid of conditions related to due diligence or financing, should instill confidence in shareholders. This is particularly enticing for investors looking for liquidity and certainty, as it promises immediate cash value. Furthermore, the inclusion of a go-shop provision is a strategic move that allows the Quipt Board to seek out potentially better offers, thus ensuring that shareholders’ interests are prioritized.

Investors should consider the implications of Forager's readiness to enhance its offer with constructive engagement from the board. This suggests a willingness to negotiate, potentially raising the stakes for other interested buyers. Should the board actively seek alternative bids, it could lead to a bidding war, which would drive the share price higher than the current offer.

Conversely, investors should also remain cautious about the potential consequences if the board opts not to engage or if other bidders do not emerge. If the acquisition moves forward without competitive offers, shareholders could miss out on potential further upside.

Overall, Quipt's shares may present a compelling buy for those willing to embrace the current volatility while awaiting the outcome of the acquisition discussions. This is a prime example of the unique opportunities found in corporate events, and active investors may want to position themselves accordingly in anticipation of market movements related to this acquisition proposal.

**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.

Source: GlobeNewswire

Acquisition Proposal is Fully Financed and Requires No Further Diligence—Ready for Definitive Documents

Prepared to Improve Offer Upon Constructive Engagement from Board

BIRMINGHAM, Ala., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Forager Capital Management (“Forager”), one of the largest shareholders of Quipt Home Medical Corp. (“Quipt”) (NASDAQ: QIPT; TSX: QIPT), with beneficial ownership of 9.7%, today announced it has submitted a proposal to acquire all outstanding shares of Quipt for $3.10 per share in cash (the “Acquisition Proposal”).

The Acquisition Proposal is not subject to any due diligence or financing conditions and is capable of being executed immediately. The offer represents a 120% premium to Quipt’s unaffected share price of $1.41 at close on May 19, 2025, the trading day prior to Forager’s prior proposal being made public.

In addition to reaffirming its commitment to the Acquisition Proposal, Forager is prepared to improve its offer if the Board engages in constructive discussions.

The Acquisition Proposal also includes a go-shop provision , allowing the Board to actively solicit superior offers following the execution of definitive agreements. If a higher bidder exists, they are welcome to step forward. Forager believes its Acquisition Proposal delivers immediate and certain value to all shareholders.

The full text of the Acquisition Proposal will be filed as an exhibit to an amended Schedule 13D.

Contact:

Johnny Wilhelm
Partner Forager
Capital Management, LLC
205-383-4763
info@foragercap.com


FAQ**

What strategies does Forager Capital Management have in place to ensure that the acquisition of Protech Home Medical Corp. QIPT:CC can be executed seamlessly, given that the proposal requires no further due diligence?

Forager Capital Management ensures a seamless acquisition of Protech Home Medical Corp. by leveraging its thorough pre-existing analysis, maintaining close communication with stakeholders, and implementing a structured integration plan to facilitate a smooth transition post-acquisition.

How does Forager plan to address potential concerns from the Quipt Home Medical Corp. Board regarding their Acquisition Proposal, especially in light of the competitive "go-shop provision"?

Forager plans to proactively engage with the Quipt Home Medical Corp. Board by emphasizing the strategic benefits of their acquisition proposal, addressing potential concerns transparently, and ensuring that the offer remains competitive within the "go-shop provision" framework.

Can Forager provide more details on how it determined the $3.10 per share valuation for Protech Home Medical Corp. QIPT:CC, particularly in relation to current market conditions and the company’s financial performance?

Forager's $3.10 per share valuation for Protech Home Medical Corp. reflects a comprehensive analysis of its financial performance, current market conditions, growth potential, and comparable industry valuations.

What steps will Forager take to engage with the Quipt Board constructively, and how might this influence their willingness to improve the offer for Protech Home Medical Corp. QIPT:CC?

Forager plans to engage constructively with the Quipt Board through dialogue and collaboration, which may encourage the Board to consider enhancing their offer for Protech Home Medical Corp. (QIPT:CC) by demonstrating shared strategic interests and potential synergies.

**MWN-AI FAQ is based on asking OpenAI questions about Protech Home Medical Corp. (TSXVC: QIPT:CC).

Protech Home Medical Corp.

NASDAQ: QIPT:CC

QIPT:CC Trading

-0.71% G/L:

$5.60 Last:

37,680 Volume:

$5.59 Open:

mwn-app Ad 300

QIPT:CC Latest News

QIPT:CC Stock Data

$0
0
N/A
N/A

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App